Annual CFF:
$140.66M+$151.52M(+1395.62%)Summary
- As of today, CPRX annual cash from financing is $140.66 million, with the most recent change of +$151.52 million (+1395.62%) on December 31, 2024.
- During the last 3 years, CPRX annual cash from financing has risen by +$148.81 million (+1827.43%).
- CPRX annual cash from financing is now at all-time high.
Performance
CPRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$872.00K-$2.19M(-71.50%)Summary
- As of today, CPRX quarterly cash from financing is $872.00 thousand, with the most recent change of -$2.19 million (-71.50%) on June 30, 2025.
- Over the past year, CPRX quarterly cash from financing has dropped by -$285.00 thousand (-24.63%).
- CPRX quarterly cash from financing is now -99.38% below its all-time high of $141.05 million, reached on March 31, 2024.
Performance
CPRX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$2.39M-$285.00K(-10.65%)Summary
- As of today, CPRX TTM cash from financing is $2.39 million, with the most recent change of -$285.00 thousand (-10.65%) on June 30, 2025.
- Over the past year, CPRX TTM cash from financing has dropped by -$129.02 million (-98.18%).
- CPRX TTM cash from financing is now -98.30% below its all-time high of $140.66 million, reached on December 31, 2024.
Performance
CPRX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CPRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1395.6% | -24.6% | -98.2% |
| 3Y3 Years | +1827.4% | +129.1% | +126.1% |
| 5Y5 Years | +10000.0% | +2308.8% | +90.6% |
CPRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1395.6% | -99.4% | +108.6% | -98.3% | +122.0% |
| 5Y | 5-Year | at high | +1395.6% | -99.4% | +108.6% | -98.3% | +122.0% |
| All-Time | All-Time | at high | +1395.6% | -99.4% | +108.6% | -98.3% | +122.0% |
CPRX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $872.00K(-71.5%) | $2.39M(-10.7%) |
| Mar 2025 | - | $3.06M(-31.0%) | $2.68M(-98.1%) |
| Dec 2024 | $140.66M(+1395.6%) | $4.43M(+174.2%) | $140.66M(+3.8%) |
| Sep 2024 | - | -$5.97M(-616.3%) | $135.57M(+3.2%) |
| Jun 2024 | - | $1.16M(-99.2%) | $131.41M(+1.1%) |
| Mar 2024 | - | $141.05M(>+9900.0%) | $130.04M(+1297.8%) |
| Dec 2023 | -$10.86M(-740.9%) | -$665.00K(+93.4%) | -$10.86M(-36.8%) |
| Sep 2023 | - | -$10.13M(-4632.2%) | -$7.94M(-228.6%) |
| Jun 2023 | - | -$214.00K(-243.6%) | $6.17M(+81.9%) |
| Mar 2023 | - | $149.00K(-93.4%) | $3.39M(+100.4%) |
| Dec 2022 | $1.69M(+120.8%) | $2.25M(-43.4%) | $1.69M(+154.9%) |
| Sep 2022 | - | $3.98M(+233.2%) | -$3.08M(+66.3%) |
| Jun 2022 | - | -$2.99M(-92.9%) | -$9.17M(+7.2%) |
| Mar 2022 | - | -$1.55M(+38.6%) | -$9.88M(-21.4%) |
| Dec 2021 | -$8.14M(-1260.1%) | -$2.53M(-20.4%) | -$8.14M(-45.6%) |
| Sep 2021 | - | -$2.10M(+43.4%) | -$5.59M(-94.2%) |
| Jun 2021 | - | -$3.71M(-2071.8%) | -$2.88M(-433.3%) |
| Mar 2021 | - | $188.00K(+634.4%) | $863.80K(+23.1%) |
| Dec 2020 | $701.90K(-37.1%) | $25.60K(-95.8%) | $701.90K(-44.1%) |
| Sep 2020 | - | $614.00K(+1596.1%) | $1.25M(+39.9%) |
| Jun 2020 | - | $36.20K(+38.7%) | $896.70K(-14.9%) |
| Mar 2020 | - | $26.10K(-95.5%) | $1.05M(-5.7%) |
| Dec 2019 | $1.12M(+280.8%) | $578.30K(+125.8%) | $1.12M(+61.9%) |
| Sep 2019 | - | $256.10K(+33.0%) | $689.60K(+28.2%) |
| Jun 2019 | - | $192.60K(+115.4%) | $538.00K(+53.9%) |
| Mar 2019 | - | $89.40K(-41.0%) | $349.50K(+19.2%) |
| Dec 2018 | $293.10K(-99.5%) | $151.50K(+45.0%) | $293.10K(-99.5%) |
| Sep 2018 | - | $104.50K(+2448.8%) | $54.28M(-2.3%) |
| Jun 2018 | - | $4100.00(-87.6%) | $55.58M(-3.1%) |
| Mar 2018 | - | $33.00K(-99.9%) | $57.38M(+0.1%) |
| Dec 2017 | $57.35M(>+9900.0%) | $54.14M(+3745.2%) | $57.35M(+1641.3%) |
| Sep 2017 | - | $1.41M(-22.0%) | $3.29M(+74.7%) |
| Jun 2017 | - | $1.81M(>+9900.0%) | $1.89M(+2248.3%) |
| Mar 2017 | - | $0.00(-100.0%) | $80.30K(+16.4%) |
| Dec 2016 | $69.00K(-99.8%) | $80.30K(>+9900.0%) | $69.00K(+27.5%) |
| Sep 2016 | - | $0.00(0.0%) | $54.10K(-94.4%) |
| Jun 2016 | - | $0.00(+100.0%) | $970.70K(-10.4%) |
| Mar 2016 | - | -$11.30K(-117.3%) | $1.08M(-97.1%) |
| Dec 2015 | $37.16M | $65.40K(-92.9%) | $37.16M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $916.60K(+711.2%) | $38.92M(+2.4%) |
| Jun 2015 | - | $113.00K(-99.7%) | $38.00M(-41.2%) |
| Mar 2015 | - | $36.06M(+1879.4%) | $64.61M(+126.2%) |
| Dec 2014 | $28.56M(+57.1%) | $1.82M(>+9900.0%) | $28.56M(+6.1%) |
| Sep 2014 | - | $0.00(-100.0%) | $26.93M(-40.0%) |
| Jun 2014 | - | $26.73M(>+9900.0%) | $44.90M(+146.8%) |
| Mar 2014 | - | $16.50K(-91.3%) | $18.20M(+0.1%) |
| Dec 2013 | $18.18M(+24.7%) | $189.80K(-98.9%) | $18.18M(-21.2%) |
| Sep 2013 | - | $17.97M(>+9900.0%) | $23.07M(+116.3%) |
| Jun 2013 | - | $23.50K(>+9900.0%) | $10.67M(-26.8%) |
| Mar 2013 | - | $0.00(-100.0%) | $14.58M(0.0%) |
| Dec 2012 | $14.58M(+163.1%) | $5.08M(-8.6%) | $14.58M(+13.8%) |
| Sep 2012 | - | $5.56M(+41.2%) | $12.81M(+76.7%) |
| Jun 2012 | - | $3.94M(>+9900.0%) | $7.25M(+118.8%) |
| Mar 2012 | - | $0.00(-100.0%) | $3.31M(-40.2%) |
| Dec 2011 | $5.54M(+280.6%) | $3.31M(>+9900.0%) | $5.54M(+148.7%) |
| Sep 2011 | - | $0.00(0.0%) | $2.23M(-39.5%) |
| Jun 2011 | - | $0.00(-100.0%) | $3.68M(0.0%) |
| Mar 2011 | - | $2.23M(>+9900.0%) | $3.68M(+153.0%) |
| Dec 2010 | $1.46M(-60.6%) | $0.00(-100.0%) | $1.46M(-71.7%) |
| Sep 2010 | - | $1.46M(>+9900.0%) | $5.15M(+39.4%) |
| Jun 2010 | - | $0.00(0.0%) | $3.70M(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) | $3.70M(0.0%) |
| Dec 2009 | $3.70M(-9.5%) | $3.70M(>+9900.0%) | $3.70M(+1127.0%) |
| Sep 2009 | - | $0.00(0.0%) | -$360.10K(-108.8%) |
| Jun 2009 | - | $0.00(0.0%) | $4.10M(+0.4%) |
| Mar 2009 | - | $0.00(+100.0%) | $4.09M(+0.0%) |
| Dec 2008 | $4.08M(>+9900.0%) | -$360.10K(-108.1%) | $4.08M(-8.1%) |
| Sep 2008 | - | $4.46M(>+9900.0%) | $4.44M(>+9900.0%) |
| Jun 2008 | - | -$17.00K(-750.0%) | -$19.00K(-850.0%) |
| Mar 2008 | - | -$2000.00(>-9900.0%) | -$2000.00(>-9900.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2007 | - | $0.00(0.0%) | $18.11M(-13.2%) |
| Jun 2007 | - | $0.00(0.0%) | $20.86M(0.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $20.86M(0.0%) |
| Dec 2006 | $20.86M(+1893.6%) | $18.11M(+557.8%) | $20.86M(+657.8%) |
| Sep 2006 | - | $2.75M | $2.75M |
| Dec 2005 | $1.05M(>+9900.0%) | - | - |
| Dec 2004 | $0.00(-100.0%) | - | - |
| Dec 2003 | $675.00K | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of CPRX is $140.66M
What is the all-time high annual cash from financing for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual cash from financing is $140.66M
What is Catalyst Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, CPRX annual cash from financing has changed by +$151.52M (+1395.62%)
What is Catalyst Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of CPRX is $872.00K
What is the all-time high quarterly cash from financing for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly cash from financing is $141.05M
What is Catalyst Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, CPRX quarterly cash from financing has changed by -$285.00K (-24.63%)
What is Catalyst Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of CPRX is $2.39M
What is the all-time high TTM cash from financing for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM cash from financing is $140.66M
What is Catalyst Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, CPRX TTM cash from financing has changed by -$129.02M (-98.18%)